From Maiharaji Altine, Gusau
As Nigerians continued to be apprehensive on the plan by the Federal Government to remove subsidy on petroleum as well as to vaccinate people with COVID 19 injections, the Governors of the 36 states, under the umbrella of the Nigeria Governors’ Forum (NGF) will meet tomorrow Thursday to discuss on the burning issues.
This was revealed by the Head of the Media and Public Affairs of the Governors’ Forum, Malam Abdulrazaque Bello-Barkindo in a statement issued to newsmen.
According to Barkindo, Governor Nasir El Rufai of Kaduna State, who is the Chairman of NGF committee on petroleum subsidy would brief his colleagues before any decisions on the supply or retailing of the product would be taken.
The Governor of Delta state, Mr. Ifeanyi Okies who is the chairman, NGF’s Committee on COVID 19 would brief his colleagues on the situation with the vaccines rolled out and their attendant encumbrances.
Meanwhile, Nigerians have continued to express total fear that prices of goods and services that have already skyrocketed as a result of the plan by the Federal Government to remove subsidy on petroleum would make life very unbearable to the people of the country who were mostly poor.
With regards to COVID 19 vaccines, many Nigerians were not in support of the vaccines as they were tested and found to have negative effects in many countries.
Germany and France are among the growing list of European countries to have suspended or limited the use of the Oxford/AstraZeneca coronavirus vaccine after reports of possible side-effects including several incidents of blood clots in people that had received the shot.
The European Medicines Agency (EMA) and the World Health Organization (WHO) have said there was no evidence so far that the severe adverse events, including at least five deaths, were caused by the vaccine but national governments have taken precautionary action regardless.
Even if no link is proven between the vaccine and the incidents so that vaccinations can restart, experts have warned the suspension is likely to damage already fragile public confidence in the Oxford/AstraZeneca shot.
